Results 131 to 140 of about 100,511 (312)

Pediatric antiarrhythmics and toxicity: A clinical review

Journal of the American College of Emergency Physicians Open
Antiarrhythmic medications are fundamental in the acute and chronic management of pediatric arrhythmias. Particularly in the pediatric patient population, associated antiarrhythmic toxicities represent important potential adverse effects.
Alexandra T. Geanacopoulos, Benjamin Zielonka, Miriam T. Fox, Sarah Kerr, Kristina D. Chambers, Robert Przybylski, Michele M. Burns   +6 more
doaj   +1 more source

Pre‐anaesthetic risk assessment and management of dogs with myxomatous mitral valve disease: a spectrum of care narrative review

Journal of Small Animal Practice, EarlyView.
Myxomatous mitral valve disease, an acquired valvular degeneration, is the most common cardiac disorder in dogs, affecting approximately 10% of dogs in primary care veterinary practice. Dogs with myxomatous mitral valve disease frequently require anaesthesia for routine procedures.
I. Levinzon, L. Köster, E. Vettorato, A. H. Estrada   +3 more
wiley   +1 more source

Therapy for patient with atrial fibrillation: in search of a balance between efficacy and safety

Клинический разбор в общей медицине
This paper analyzes aspects of the efficacy and safety of antiarrhythmic drugs in the treatment of atrial fibrillation. It considers drug-drug interactions of antiarrhythmics with other drugs, especially in the near circle, i.e.
Yakov G. Bozhko, Inna I. Reznik, Mikhail V. Arkhipov   +2 more
doaj   +1 more source

Modified Anatomical Ablation Strategy for Mitral Isthmus

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Durable mitral isthmus (MI) block remains challenging in persistent atrial fibrillation (AF) ablation. Ethanol infusion into the vein of Marshall (EI‐VOM) enhances efficacy, but the minimal endocardial ablation extent post‐EI‐VOM is undefined.
Kui He, Yifei Lu, Yuan Zhang, Tao Li, Mengqi Yang, Jiangbo Lin, Weili Ge, Yafei Mi   +7 more
wiley   +1 more source

Safety issues of antiarrhythmic therapy for atrial fibrillation

Клинический разбор в общей медицине
The article discusses the safety of antiarrhythmic therapy for atrial fibrillation in the light of the development of cardiac and non-cardiac side effects, the presence of drug-drug interactions of antiarrhythmic drugs in the near (with anticoagulants ...
I.I. Reznik , Ya.G. Bozhko
doaj   +1 more source

Pulmonary Vein Isolation in Elderly Patients With Atrial Fibrillation and Symptomatic Sick Sinus Syndrome: A Case Series

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT In patients with atrial fibrillation (AF), sinus node disease (SND) represents a potentially reversible concomitant condition. Initial treatment with catheter ablation (CA) aimed at restoration of sinus rhythm may provide an alternative to pacemaker implantation. In this case series, 15 elderly patients (>65 years) with AF and SND underwent CA,
Cerine Benachi, Patrick Nagel, Johannes Lucas, Ulf Landmesser, Gerhard Hindricks, Verena Tscholl, Sebastian Biewener, Martin Huemer, Philipp Attanasio, Tobias Schreiber   +9 more
wiley   +1 more source

Incidence and Determinants of Implantable Cardioverter‐Defibrillator Therapy With Loss of and Impaired Consciousness

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Introduction Implantable cardioverter‐defibrillators (ICDs) are important in the prevention of sudden cardiac death. However, some appropriate ICD therapies may be considered unnecessary, delivered when patients do not experience symptoms of hemodynamic instability such as loss of consciousness.
Alwin B. P. Noordman, Michiel Rienstra, Yuri Blaauw, Bart A. Mulder, Hessel Groenveld, Alexander H. Maass   +5 more
wiley   +1 more source

CHARACTERISTICS OF COMBINED USE OF MEXICOR TOGETHER WITH SOME ANTIARRHYTHMIC DRUGS IN ACUTE OCCLUSION OF CORONARY ARTERY IN EXPERIMENTAL STUDY

Российский кардиологический журнал, 2003
The aim of the study was to assess the influence of intravenous administration of mexicor (7mg / kg) on electrophysiological, hemodynamic action and antiarrhythmic activity of nibentan (1 mg / kg), propranolol (1,4mg / kg) and verapamil (0,4mg / kg) in ...
A. A. Kotljarov, L. N. Sernov
doaj  

Long‐Term Outcomes of Radiofrequency Atrioventricular Node Ablation in a Real‐World Population

Pacing and Clinical Electrophysiology, EarlyView.
Abstract Background While interventional strategies have expanded the options for long term rhythm restoration, rate control continues to play a pivotal role in the treatment of atrial arrhythmias; however, pharmacologic strategies alone often fail in achieving effective rate control.
Vanessa Sciacca, Nora‐Kristin Brandt, Thomas Fink, Denise Guckel, Maximilian Mörsdorf, Yuri Bocchini, Martin Braun, Moneeb Khalaph, Karen Harutyunyan, Nadica Trajkovska, Philipp Lucas, Thomas Eitz, Maxim Didenko, Philipp Sommer, Christian Sohns   +14 more
wiley   +1 more source

Drug Therapy in Atrial Fibrillation Management: Where Do We Stand in 2010? [PDF]

Journal of Tehran University Heart Center, 2010
Atrial fibrillation (AF) is a commonly encountered arrhythmia in our daily practice. Every year a huge bulk of data is published about different management strategies, new antiarrhythmic drugs, anticoagulation protocols and ablation procedures in these ...
Mehdi Montazeri, Gholamreza Davoodi
doaj